If you have a history of eating disorders, discuss this openly with your provider before beginning any weight loss medication
FDA Issues 30 Warning Letters to Telehealth Firms Over Misleading Compounded GLP-1 Marketing Stephen Appezzato Key Takeaways Thirty telehealth firms received warning letters for illegal promotion of compounded semaglutide/tirzepatide, reflecting an expanded enforcement tempo that now surpasses the prior decades letter volume
If you have severe or lasting side effects, contact your practitioner for advice
Proper technique, sterile equipment, and appropriate frequency minimize these risks
[DOI] [PMC free article] [PubMed] [Google Scholar] 19.Vern GL, Tissera AD, Bello R, Beltramone F, Estofan G, Molina RI, et al